<DOC>
	<DOC>NCT00686933</DOC>
	<brief_summary>The objective of this study is to evaluate the long-term effects and tolerability of ABT-089 in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).</brief_summary>
	<brief_title>Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>The subject was randomized into Study M10346 and completed the study. Female subjects of childbearing potential must have a negative urine pregnancy test at screening and baseline and agree to comply with applicable contraceptive requirements. Male subjects must agree to comply with applicable contraceptive requirements. The subject is judged to be in generally good health. The subject has taken any ADHD medication between the last dose of study drug in Study M10346 and the first dose of study drug in the current study. The subject anticipates a move outside the geographic area.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Attention-Deficit/Hyperactivity Disorder</keyword>
</DOC>